Literature DB >> 2828265

Recovery of herpes simplex virus from ocular tissues of latently infected inbred mice.

S Z Abghari1, R D Stulting.   

Abstract

Evidence for latent infection of ocular tissues following topical corneal inoculation with herpes simplex virus type 1 (HSV) was sought in three strains of inbred mice that differ in susceptibility to HSV stromal keratitis. Corneas of BALB/c, C57BL/6, and DBA/2 mice were inoculated topically with HSV. At 6-8 weeks after inoculation, when no active ocular infection was present, minced whole eyes and trigeminal ganglia were assayed for latent virus. Virus was recovered by explantation from minced eyes of all three strains (DBA/2 = 20%; BALB/c = 17%; C57BL/6 = 7%). In order to determine which ocular structures harbored virus, corneas, retinas and choroid-sclera were cultivated separately. Virus was activated from corneas of DBA/2 and BALB/c mice, but not from corneas of C57BL/6 mice. These findings suggest that HSV is capable of establishing latent infection in ocular tissue of inbred mice and that the rate of establishment of latency is under host genetic control. Since neural cell bodies are not present in the cornea, the data suggest that latency is established in cells other than neurons.

Entities:  

Mesh:

Year:  1988        PMID: 2828265

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

Review 1.  Herpes simplex virus ocular infections: current concepts of acute, latent and reactivated disease.

Authors:  D Pavan-Langston
Journal:  Trans Am Ophthalmol Soc       Date:  1990

Review 2.  Human herpesviruses: a consideration of the latent state.

Authors:  J G Stevens
Journal:  Microbiol Rev       Date:  1989-09

3.  Latency-associated transcripts in corneas and ganglia of HSV-1 infected rabbits.

Authors:  S D Cook; J M Hill; C Lynas; N J Maitland
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

Review 4.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

Review 5.  Ocular herpes simplex virus type 1: is the cornea a reservoir for viral latency or a fast pit stop?

Authors:  David P Kennedy; Christian Clement; Richard L Arceneaux; Partha S Bhattacharjee; Tashfin S Huq; James M Hill
Journal:  Cornea       Date:  2011-03       Impact factor: 2.651

6.  Corneal latency and transmission of herpes simplex virus-1.

Authors:  Asim V Farooq; Deepak Shukla
Journal:  Future Virol       Date:  2011-01       Impact factor: 1.831

Review 7.  Molecular biology of herpes simplex virus type 1 latency in the nervous system.

Authors:  I Steiner; P G Kennedy
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

8.  Non-traumatic acquisition of herpes simplex virus infection through the eye.

Authors:  S B Kaye; C Shimeld; E Grinfeld; N J Maitland; T J Hill; D L Easty
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

9.  Evidence for herpes simplex viral latency in the human cornea.

Authors:  S B Kaye; C Lynas; A Patterson; J M Risk; K McCarthy; C A Hart
Journal:  Br J Ophthalmol       Date:  1991-04       Impact factor: 4.638

Review 10.  Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseases.

Authors:  Jody M Webre; James M Hill; Nicole M Nolan; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Victor Hsia; Donna M Neumann; Timothy P Foster; Walter J Lukiw; Hilary W Thompson
Journal:  J Biomed Biotechnol       Date:  2012-10-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.